News / Business
Best Pharmaceutical Stock - (NASDAQ:AVNR) - Today’s Top Percentage Gainer
AVANIR Pharmaceuticals (NASDAQ:AVNR) Is Today’s Top Percentage Gainer
AVANIR Pharmaceuticals (NASDAQ:AVNR) climbed 10%to $2.53 on massive volume of 2.60 million shares after it announced additional detailed results from the confirmatory double blind Phase III STAR trial evaluating two doses of the investigational drug Zenvia (dextromethorphan/quinidine) compared to placebo in the treatment of pseudobulbar affect (PBA) among patients with underlying multiple sclerosis (MS) or amyotrophic lateral sclerosis (ALS). Over the course of the 12 week study in the MS patient subset, Zenvia 30/10 mg met the primary efficacy endpoint by reducing PBA episode rates by an incremental 11.9% beyond placebo (p=0.0280). The lower dose Zenvia 20/10 mg group did not achieve a statistically significant reduction in PBA episode rates compared to placebo.
Avanir Pharmaceuticals is a pharmaceutical company focused on developing, acquiring and commercializing therapeutic products for the treatment of chronic diseases. The Company’s product candidates address therapeutic markets that include the central nervous system and inflammatory diseases.
ABOUT PennyStockPickReport.com
www.pennystockpickreport.com is one of the leading stock web site that provides free stock alerts and tracks small cap penny stocks that could be on the brink of a massive breakout. If you wish to get your company featured on our website then please contact us at info @PennyStockPickReport
